Compounds represented by formula (I) wherein A, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.

 
Web www.patentalert.com

> Heteroarylpyrrolopyridinones active as kinase inhibitors

~ 00357